Skip to main content
logo
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.370
0.00 (0.00%)
Sep 17, 2026, 4:00 PM EDT - Market closed

ZYBT Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
116.36116.36186.36211.65260.27214.07
Revenue Growth
-24.31%-37.56%-11.95%-18.68%21.58%-
Gross Profit
23.8723.8791.3117.51147.88124.62
Operating Income
-70.51-70.5116.4444.9965.8352.47
Net Income
-69.78-69.7811.3131.4646.7438.96
Earnings Per Share
-1.47-1.470.250.691.020.85
EPS Growth
---64.04%-32.69%19.96%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
51.8951.8920.0416.39.756.28
Total Debt
75.0875.0886.5889.8564.8830
Net Cash (Debt)
-23.19-23.19-66.54-73.55-55.13-23.72
Net Cash Growth
------
Net Cash Per Share
-0.49-0.49-1.46-1.61-1.21-0.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
13.3313.3341.0548.1817.3431.81
Capital Expenditures
-1.01-1.01-13.59-7.4-27.33-19.06
Free Cash Flow
12.3312.3327.4640.79-9.9912.75
Free Cash Flow Growth
3927.78%-55.12%-32.68%---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
20.51%20.51%48.99%55.52%56.82%58.22%
Operating Margin
-60.59%-60.59%8.82%21.25%25.30%24.51%
Pretax Margin
-61.77%-61.77%7.72%20.68%24.56%24.79%
Profit Margin
-59.97%-59.97%6.07%14.86%17.96%18.20%
FCF Margin
10.59%10.59%14.74%19.27%-3.84%5.96%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
35.3330.93----
PS Ratio
3.903.28----